Air Liquide stock trades steadily as fundamentals and valuation stay in focus

Air Liquide S.A. (FR0000120628) stock offers investors a mix of defensive industrial gas cash flows and a premium valuation backdrop as of August 25, 2026, with recent data highlighting strong margins and a sizable market capitalization. The latest market snapshot as of August 21, 2026 shows a market cap of $124.32 billion and a trailing price-to-earnings ratio of 29.99, indicating that the market continues to pay up for the company’s earnings stream per recent market-data disclosures. For investors, the combination of solid profitability and high multiples makes the balance between growth prospects and valuation risk an important consideration.

Profitability metrics underpin the Air Liquide stock story

Recent compiled data on Air Liquide’s financial profile as of August 21, 2026 points to robust profitability that helps justify its current valuation levels. According to a detailed market overview the company’s trailing twelve month revenue is reported at $27.05 billion, with net income attributable to common shareholders of $3.54 billion. These figures translate into a profit margin of 13.09 percent on a trailing basis, giving investors a clear sense of the company’s ability to convert sales into bottom-line earnings over the latest reported twelve month period. In practice, this margin means that for every $100 of revenue Air Liquide generates over that span, it retains a little more than $13 as net profit, a solid level for a capital-intensive industrial business.

The same market-data snapshot shows a return on equity of 13.97 percent and a return on assets of 6.34 percent on a trailing twelve month basis, underscoring how effectively the company uses both its asset base and shareholder capital. When these profitability metrics are viewed together with the trailing revenue and net income figures, they illustrate that Air Liquide is not merely a defensive name but also a business that has been generating attractive returns from the most recent twelve month reporting window. Investors often compare such returns to those of other large industrial or chemical companies; a double digit return on equity in the latest period suggests that Air Liquide remains competitive on capital efficiency.

One quantified comparison that stands out for Air Liquide is the relationship between its current valuation and its revenue base. With a market cap of $124.32 billion and trailing twelve month revenue of $27.05 billion as of August 21, 2026, the company trades at roughly 4.6 times its latest annualized sales figure when using the reported price-to-sales ratio of 3.92 and the enterprise value-to-revenue ratio of 4.49 from the same data set. This level of valuation multiple is higher than what many cyclical industrial businesses trade at, reflecting that investors are willing to assign a premium to Air Liquide’s earnings quality and growth potential, but it also points to limited room for disappointment in future quarters.

Balance sheet, cash generation and valuation context

Beyond revenue and net income, the latest compiled metrics emphasize the state of Air Liquide’s balance sheet and cash generation capability. As of the most recent quarter in 2026 covered by the same market-data source, total cash is reported at $2.06 billion, while the total debt-to-equity ratio stands at 63.31 percent. This level of leverage indicates that the company makes meaningful use of debt financing but remains within a range that many investors would view as manageable for a stable, cash-generating industrial group. The relationship between cash, debt and equity is central to evaluating whether the current valuation properly reflects financial risk, and the reported leverage ratio suggests that Air Liquide is not overextended on a structural basis.

On the cash flow side, the trailing twelve month levered free cash flow is indicated at $264.44 million in the same overview, meaning that after servicing debt-related commitments, the company still produced a positive free cash flow figure over the latest twelve month window. While this amount is modest relative to the $3.54 billion of net income reported for that period, it still represents a surplus that can support dividends, selective investment and potential debt reduction. The gap between accounting earnings and free cash flow is an important analytical point for investors in Air Liquide stock, because it highlights that while profitability is strong, capital expenditure and working capital needs absorb a significant portion of cash generation, a common feature in capital-intensive industries.

Valuation metrics further frame the investment case for Air Liquide as of late August 2026. The trailing price-to-earnings ratio of 29.99 and forward price-to-earnings ratio of 23.98, as reported in the most recent market-data set, show that the market expects meaningful earnings growth in the coming periods. The reduction from the trailing to the forward P/E implies that consensus forecasts anticipate higher earnings in future fiscal periods, which is a positive signal on growth expectations. At the same time, a forward multiple in the mid-20s range is not low relative to many global industrial peers, suggesting that investors who buy the stock at current levels are paying a premium for the perceived reliability and growth trajectory of Air Liquide’s operations.

The company’s PEG ratio for the next five years is cited at 2.18 in the same data set, which incorporates both the current valuation and projected earnings growth. A PEG ratio above 1 often indicates that valuation is demanding relative to growth expectations; in Air Liquide’s case, a figure above 2 shows that while growth is expected, the premium investors assign to the shares is substantial. For long-term shareholders, this adds to the importance of monitoring whether actual earnings and cash flow developments over the next several quarters meet or exceed these embedded expectations, because any significant shortfall could pressure the stock price and multiples.

Market performance and index comparison

From a market performance standpoint, Air Liquide’s stock has posted positive year-to-date returns as of late August 2026, which aligns with its position as a large component of the French equity market. The latest performance table for the company’s shares, compiled as of August 24, 2026, lists a variety of trailing total return metrics relative to a benchmark index. The year-to-date total return figure is stated at 6.23 percent as of August 24, 2026, which indicates that investors in Air Liquide stock have seen their holdings appreciate over the course of 2026, including dividends and other distributions. This performance is notable given that broader European markets have faced periods of volatility in 2026, so a positive single-digit total return highlights the stock’s resilience.

In addition to the year-to-date figure, other trailing return measures over different horizons show a similar pattern of steady performance. For instance, the same performance table includes total return values of 3.72 percent, 6.53 percent and 6.06 percent over selected rolling periods up to August 24, 2026, illustrating that the stock has delivered modest but positive returns across multiple time frames. These numbers provide a quantified comparison between holding Air Liquide and broader equity exposure, particularly in light of the benchmark index cited in the performance overview. For income-oriented investors, the presence of distributions in these total return calculations reiterates that the stock combines dividend income with capital appreciation.

The stock’s linkage to the French benchmark index also matters from a portfolio-construction angle. The referenced market-data page notes that the benchmark for Air Liquide’s trailing total return comparison is the CAC 40, underscoring the company’s role as a key constituent of this leading French index. For global investors using exchange-traded funds or index products that track the CAC 40, Air Liquide’s share price and return profile directly influence overall index performance. As of August 25, 2026, the fact that Air Liquide’s year-to-date total return remains in positive territory implies that it has contributed constructively to index-level outcomes in 2026, rather than acting as a drag.

Representative product and industrial gas demand

A representative product area for Air Liquide is the supply of medical oxygen and related gases to healthcare providers, which sits alongside its broader industrial gas solutions for manufacturing, electronics and energy. Medical oxygen is a core part of the company’s portfolio and is sold to hospitals and clinics that require reliable, high-purity gas for patient care. Demand for medical gases tends to be stable and closely linked to healthcare activity levels, providing Air Liquide with a relatively predictable revenue stream from this segment across economic cycles. This stability in medical and healthcare-related revenues complements more cyclical industrial segments, helping explain why the company’s profit margin and returns on capital have remained robust over the latest twelve month reporting period.

Stock price context and trading venue

Air Liquide’s primary listing is on Euronext Paris, where its shares trade in euros and form part of the CAC 40 index, while the company is also represented in the United States via an over-the-counter American depositary receipt under the symbol AIQUY. As of August 21, 2026, the latest market snapshot for AIQUY indicates a price of $39.22 per ADR at 1:30 p.m. EDT on that trading day, with the market open at that time. This price level, when combined with the reported market cap of $124.32 billion as of the same date, reinforces that Air Liquide remains one of the larger global industrial gas companies by equity market value. For investors watching the stock from a US perspective, the ADR offers a convenient vehicle to gain exposure to the underlying Euronext-listed shares while dealing in US dollars.

Read more

For more detailed information on Air Liquide’s investor presentations, strategy updates and financial reporting, investors can consult the company’s dedicated investor relations portal on the Air Liquide corporate website, which provides access to quarterly results, annual reports and guidance commentary.

Air Liquide medical oxygen

Within Air Liquide’s product lineup, medical oxygen stands out as a crucial offering for hospitals and healthcare providers worldwide. The company delivers medical oxygen via pipelines, cylinders and on-site production systems, aiming to ensure uninterrupted supply for operating rooms, intensive care units and general patient wards. Given that the latest trailing twelve month financial figures show $27.05 billion in revenue and $3.54 billion in net income, the contribution from resilient medical and healthcare demand forms part of the foundation underpinning these results. As healthcare systems continue to invest in infrastructure and preparedness, demand for reliable medical gases such as oxygen is likely to remain a strategic focus for Air Liquide.

Fact box

Company: Air Liquide S.A.
ISIN: FR0000120628
Ticker: AIQUY (ADR), AI on Euronext Paris
Exchange: OTC Markets (AIQUY), Euronext Paris (AI)
Price (as of August 21, 2026, 1:30 p.m. EDT): $39.22 USD
Market cap: $124.32 billion (as of August 21, 2026)
Sector / Industry: Industrials / Industrial gases and chemicals
Index membership: CAC 40